For many individuals, they provide an effective tool for reducing appetite, improving portion control and achieving meaningful weight loss
In the liver, GLP-1 receptor agonists primarily exert indirect effects through improved insulin sensitivity, reduced glucagon secretion, and weight loss
Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small intestine releases after you eat
Whether that specificity translates to superior clinical outcomes remains to be proven through rigorous trials
Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products